Robotic Prostatectomy in China: What the Treatment Can and Cannot Address

What the Operation Is Designed to Do

A radical prostatectomy is an operation to remove the prostate gland. It is offered for selected prostate cancers, meaning the cancer type, stage and risk features must fit the operation's purpose. The robotic system does not decide anything; the surgeon controls the instruments through small openings. The operation is therefore a surgical treatment for the prostate and the cancer contained within it, not a general cancer therapy.

This distinction matters when you are deciding whether to travel for care. The question is not simply whether a hospital in China has a robotic system. The question is whether the clinical team judges that removing your prostate addresses the cancer you actually have, based on your pathology, imaging and staging. If the cancer has features suggesting it has already moved beyond the prostate, surgery alone may not be the right tool, and the team may discuss other approaches or combinations. That judgement belongs to the treating clinicians, not to a coordination service.

Ask the team to explain, in plain terms, what they believe the operation will achieve for your specific cancer and what it will not. A useful answer names the intended cancer-control goal, the structures that will be removed, and the uncertainties that remain after surgery.

Cancer Control: What Surgery Can and Cannot Promise

The purpose of removing the prostate is to remove the cancer within it. For selected cancers confined to the prostate, that is the core cancer-control aim. What surgery cannot promise is a cure in every case. Some cancers have microscopic features that are not visible on scans before surgery, and the final pathology report after the operation may change the picture. If cancer cells are found at the surgical margin or in nearby tissue, the team may recommend additional monitoring or treatment.

This is why the staging work-up before surgery matters so much. Your PSA history, biopsy results, Gleason score or grade group, imaging and clinical stage all feed into the decision. If any of these are missing or unclear, the team cannot give you a meaningful view of whether surgery is appropriate. A records-based review can help organise the file, but it does not replace the hospital's own assessment or establish that you are a surgical candidate.

Ask directly: what is the goal of surgery in my case, and what would make you recommend a different approach? Ask what the plan would be if the final pathology shows something unexpected. You are not asking for a guarantee, which no clinician can give. You are asking how the team thinks about risk and next steps.

Functional Outcomes: Continence and Sexual Function

Removing the prostate sits close to the muscles and nerves that control urination and erectile function. Surgeons aim to preserve these where the cancer allows, but preservation depends on the cancer's location and extent, your baseline function and the anatomy encountered during the operation. No responsible team can promise that you will remain continent or that sexual function will be unchanged.

This is one of the hardest parts of the decision, and it is individual. Age, existing urinary and erectile function, other health conditions and the cancer's features all influence what is realistic. The team should discuss these trade-offs with you before surgery, not after. If a hospital presents robotic surgery as risk-free or as always preserving function, that is a reason to ask more questions, not fewer.

Ask how the team weighs cancer control against functional preservation in your case. Ask what support is available if continence or sexual function is affected, and who provides it. Ask whether the plan includes pelvic floor muscle training and when it would start. These are practical questions that shape recovery, and the answers should come from the treating clinicians.

Staging, Biopsy and the Records the Team Needs

The hospital cannot judge suitability from a diagnosis label alone. It needs the actual records: pathology reports from the biopsy, including grade information; PSA results over time; imaging reports such as MRI or bone scan where performed; a summary of treatments and medicines; and a clear statement of your main question. If a record is missing, the team may ask for it or explain how it affects their assessment.

Pathology review is a specific point to clarify. Some hospitals re-review biopsy slides or blocks before deciding on surgery. Ask whether the team wants the original slides or blocks sent, or whether reports are sufficient for the first review. This is an administrative question with clinical consequences, and the answer varies by hospital. Do not assume that sending a report is the same as sending the material.

When you contact a hospital or coordination service, start with a short summary rather than a complete archive. You can explain your diagnosis, the treatment you are considering and your main question. The team can then tell you which documents it needs and how to send them. This keeps the first step manageable and avoids sending sensitive material before it is needed.

Catheter Care, Hospital Stay and Recovery Support

After radical prostatectomy, a urinary catheter is typically left in place for a period, and the hospital gives instructions on care, emptying and what to watch for. The exact duration and the follow-up arrangements are clinical decisions for the treating team. Do not rely on general timelines from the internet; ask the hospital what it plans for you and what symptoms should prompt urgent contact.

Recovery support also includes practical matters. You may need to plan for time away from work, help with travel and accommodation, and a clear understanding of when you can fly home. Fitness-to-travel timing is a clinical judgement, not a logistics decision. Ask the surgeon when it is safe for you to travel and what arrangements should be in place before you leave the hospital's care.

Continuing follow-up is part of the plan, not an afterthought. PSA monitoring after surgery is standard in prostate cancer care, but the interval and the person responsible for it should be confirmed. If you return home, ask how the hospital will share records with your local clinician and who will review the results. A clear handover reduces the risk of a gap in follow-up.

Questions That Shape the Decision and the Next Step

The most useful preparation is a short list of questions that only the treating team can answer. What is the cancer-control goal of surgery in my case? What are the alternatives, and why might one be preferred? What is my baseline function, and how does that affect the plan? What does the hospital's written plan include for staging review, pathology review, catheter care and follow-up? What would the team do if the final pathology differs from the pre-operative assessment?

These questions are not a test of the surgeon. They are how you understand whether the operation addresses your cancer and what it cannot address. A team that answers them clearly, including the uncertainties, is giving you better information than one that promises outcomes.

If you are considering care in China, you can begin with a free initial case review. Our team checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. This is not a diagnosis or a promise of acceptance, and it does not replace the hospital's assessment. You can share a brief summary first and send records after the team explains what is needed. The hospital decides suitability, and the treating clinicians decide the plan.

For more detail on the procedure itself, see the robotic radical prostatectomy reference page. It explains the operation and what to prepare, while this guide focuses on what the treatment can and cannot address.

Related treatment reference